|
|
|
14.07.26 - 04:48
|
Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus (RTTNews)
|
|
|
Today's top biotech gainers include Q32 Bio, following positive Phase 2 results for its hair loss treatment; Agenus, as it advances development of its colon cancer drug combination, botensilimab and balstilimab; and Shoulder Innovations, which recently raised its full-year revenue guidance, among others....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27.05.26 - 14:01
|
Q32 Bio Announces $55 Million Private Placement Financing (PR Newswire)
|
|
|
WALTHAM, Mass., May 27, 2026 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio" or "Company"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today announced that it has entered......
|
|
|
|
|
|
|
|
|
|
|
|
|
|